List of shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company on 3 April 2023

Current Report No. 17/2023

Date of preparation: 7 April 2023

Subject: List of shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company on 3 April 2023

The Management Board of Captor Therapeutics S.A. with its registered office in Wroclaw (the “Company”) provides the list of shareholders of the Company holding at least 5% of votes at the Extraordinary General Meeting (the “EGM”) of the Company which was held on 3 April 2023:

1. Michał Walczak which entitled him to 1,496,145 votes at the EGM, constituting 35.02% of votes at the EGM and 27.93% of the total number of votes;
2. Paweł Holstinghausen Holsten which entitled to 950,041 votes at the EGM, constituting 22,24% of votes at the EGM and 17,74% of the total number of votes;
3. Sylvain Cottens which entitled to 526,730 votes at the EGM, constituting 12,33% of votes at the EGM and 9.83% of the total number of votes;
4. Funds Managed by Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. (Nationale-Nederlanden Dobrowolny Fundusz Emerytalny, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2025, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2030, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2035, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2040, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2050, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2045, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2055, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2060, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2065, Nationale-Nederlanden Otwarty Fundusz Emerytalny), which entitled to 351,073 votes at the EGM, constituting 8,22% of votes at the EGM and 6.55% of the total number of votes.